This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Tuesday, July 25, 2017
Watch Action Hepatitis Canada - Why We Need a National Strategy for Hepatitis C
No comments:
Post a Comment